Search

Your search keyword '"Thurman, Robert"' showing total 496 results

Search Constraints

Start Over You searched for: Author "Thurman, Robert" Remove constraint Author: "Thurman, Robert"
496 results on '"Thurman, Robert"'

Search Results

6. Table S1 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

7. Figure S2 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

8. Data from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

9. Supplementary Data from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

10. Mouse regulatory DNA landscapes reveal global principles of cis-regulatory evolution

11. Nonfucosylation of an anti-TIGIT antibody enhances FcγR engagement, driving innate immune activation and antitumor activity

12. Comprehensive analysis of the chromatin landscape in Drosophila melanogaster

13. SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models

14. Brentuximab Vedotin-Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

15. HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer

16. Figure S4 from HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer

17. Supplementary Materials and Methods from HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer

18. Data from HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer

21. Supplementary Methods from SGN-CD228A Is an Investigational CD228-Directed Antibody–Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models

22. Data from SGN-CD228A Is an Investigational CD228-Directed Antibody–Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models

23. Supplementary Figures from SGN-CD228A Is an Investigational CD228-Directed Antibody–Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models

24. Supplementary Tables from SGN-CD228A Is an Investigational CD228-Directed Antibody–Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models

26. SGN-CD228A is an investigational CD228-directed antibody-drug conjugate with potent antitumor activity across a wide spectrum of preclinical solid tumor models

27. Mapping and Dynamics of Regulatory DNA and Transcription Factor Networks in A. thaliana

30. Meditation and Education: India, Tibet, and Modern America

31. Cell-of-origin chromatin organization shapes the mutational landscape of cancer

32. Systematic Localization of Common Disease-Associated Variation in Regulatory DNA

33. Abstract 1281: SGN-B7H4V shows immunomodulatory activity through induction of immunogenic cell death

35. Flexibility in Program Planning and NCATE Standards.

36. Topologically associating domains are stable units of replication-timing regulation

37. A comparative encyclopedia of DNA elements in the mouse genome

38. Conservation of trans-acting circuitry during mammalian regulatory evolution

39. Domains of genome-wide gene expression dysregulation in Down's syndrome

41. Integrative analysis of 111 reference human epigenomes

43. An integrated encyclopedia of DNA elements in the human genome

44. The accessible chromatin landscape of the human genome

45. An expansive human regulatory lexicon encoded in transcription factor footprints

48. MOUSE GENOMICS: Mouse regulatory DNA landscapes reveal global principles of cis-regulatory evolution

49. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

Catalog

Books, media, physical & digital resources